FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4129011000001104: Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
567781000001111 Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
567791000001113 Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Is a Tetracosactrin 250micrograms/1mL injection false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has active ingredient Pituitary hormone false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has active ingredient Tetracosactide true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has active ingredient Tetracosactide acetate false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Is a Synacthen true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has specific active ingredient Tetracosactide acetate false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has specific active ingredient Tetracosactide acetate true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Is a Tetracosactide 250micrograms/1ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Is a Tetracosactide 250micrograms/1ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 5 ampoule Is pack of False Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 5 ampoule Has AMP True Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 1 ampoule Has AMP True Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start